Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension ...

Find out about this new study that suggest that the lung scarring that severe asthma can cause could be reversible.

Christopher Carlin, MBChB, PhD, explores the potential of AI-driven insights to enhance COPD care and identify candidates for biologic therapy.

Prescribing the biologic drug sotatercept alongside standard treatment for pulmonary arterial hypertension significantly reduces the likelihood of worsening disease when added within the first year ...

Shares of Nuvation Bio climbed after the company said it has enrolled the first patient in a Phase 3 study for a treatment for early-stage non-small cell lung cancer. The stock rose 13% to $3.64 on ...

Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in ...

Lung cancer continues to be the leading cause of cancer death in the U.S., but screening rates for this deadly disease are ...

MRI does not use ionizing radiation, so there is not a risk of cancer as there is from excess X-rays and CT scans.

Treating patients with combination therapy approaches may improve survival for patients with EGFR-positive lung cancer when compared with monotherapy treamtents, such as giving Tagrisso (osimertinib) ...

D Molecular Therapeutics (FDMT) offers attractive growth potential with strong cash reserves and promising late-stage gene ...

Experts at European Respiratory Society (ERS) Congress 2025 highlight the critical link between reduced lung function and ...

Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary ...